• Latest Posts

UroGen completes bladder cancer phase 3 trial enrollment 

SoftOx receives chronic wound study report

Astellas gastric cancer drug meets phase 3 primary endpoint

NMD Pharma cleared for spinal muscular atrophy trial

ImaginAb launches trial to study neoadjuvant immunotherapy

Asieris doses first patient in bladder cancer diagnostic trial

ADVERTISEMENT

Ascletis announces positive COVID-19 trial results

Poolbeg influenza trial successfully completed

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

Enterome completes patient enrollment for recurrent glioblastoma study

New targeted drug shows benefit against breast cancer in first phase III trial

PDC*line Pharma presents first immunological results from trial with PDC*lung01

ADVERTISEMENT